檢索結果 - Lisa Sproat

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo

    CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo 由 Leena Chaudhuri, Nicole D. Vincelette, Brian D. Koh, Ryan M. Naylor, Karen S. Flatten, Kevin L. Peterson, Andrew McNally, Ivana Gojo, Judith E. Karp, Ruben A. Mesa, Lisa Sproat, James M. Bogenberger, Scott H. Kaufmann, Raoul Tibes

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Genetic features and clinical outcomes of patients with isolated and comutated<i>DDX41</i>-mutated myeloid neoplasms

    Genetic features and clinical outcomes of patients with isolated and comutated<i>DDX41</i>-mutated myeloid neoplasms 由 Hassan B. Alkhateeb, Ahmad Nanaa, David S. Viswanatha, James M. Foran, Talha Badar, Lisa Sproat, Rong He, Phuong L. Nguyen, Dragan Jevremović, Mohamad E. Salama, Patricia T. Greipp, Naseema Gangat, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Mrinal M. Patnaik, Aref Al‐Kali

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial

    Allogeneic Hematopoietic Cell Transplant for HIV Patients with Hematologic Malignancies: The BMT CTN-0903/AMC-080 Trial 由 Richard F. Ambinder, Juan Wu, Brent R. Logan, Christine M. Durand, Ryan K. Shields, Uday Popat, Richard F. Little, Deborah K. McMahon, Joshua C. Cyktor, John W. Mellors, Ernesto Ayala, Lawrence D. Kaplan, Ariela Noy, Richard J. Jones, Alan Howard, Stephen J. Forman, David Porter, Carlos Arce‐Lara, Paul Shaughnessy, Lisa Sproat, Shahrukh K. Hashmi, Adam Mendizabal, Mary M. Horowitz, Willis H. Navarro, Joseph Alvarnas

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients

    Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients 由 Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla McKerrow Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al‐Kali, Hassan B. Alkhateeb, Kebede H. Begna, Abhishek A. Mangaonkar, Antoine N. Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Ayalew Tefferi

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival

    Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and sur... 由 Omer Karrar, Maymona Abdelmagid, Masooma Shifa Rana, Moazah Iftikhar, Kristen McCullough, Aref Al‐Kali, Hassan B. Alkhateeb, Kebede H. Begna, Michelle A. Elliott, Abhishek A. Mangaonkar, Antoine N. Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Ayalew Tefferi, Naseema Gangat

    出版 2023
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  6. 6
    Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

    Factors associated with survival following allogeneic transplantation for myeloid neoplasms harboring TP53 mutations 由 Anmol Baranwal, Kimberly J. Langer, Vedavyas Gannamani, Danielle Rud, Alia Cibich, Caner Saygin, Mariam T. Nawas, Talha Badar, Mohamed A. Kharfan‐Dabaja, Ernesto Ayala, Vivek Roy, James M. Foran, Hemant S. Murthy, Madiha Iqbal, Jeanne Palmer, Lisa Sproat, Saurabh Chhabra, Nandita Khera, Mehrdad Hefazi, Abhishek A. Mangaonkar, William J. Hogan, Mark R. Litzow, Hassan B. Alkhateeb, Ayalew Tefferi, Chung Hoow Kok, Guru Subramanian Guru Murthy, Anand Patel, Ashish Bajel, Devendra Hiwase, Mithun Vinod Shah

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent

    Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent 由 Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna, Isla McKerrow Johnson, Maymona Abdelmagid, Aref Al‐Kali, Hassan B. Alkhateeb, Kebede H. Begna, Michelle A. Elliott, Abhishek A. Mangaonkar, Aasiya Matin, Antoine N. Saliba, Mehrdad Hefazi, Mark R. Litzow, William J. Hogan, Mithun Vinod Shah, Mrinal M. Patnaik, Animesh Pardanani, Talha Badar, Hemant S. Murthy, James M. Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Y. Arana Yi, Samuel J. Yates, Abigail Sneider, Emily Dworkin, Anand Patel, Alexandre Bazinet, Jayastu Senapati, Álex Bataller, Courtney D. DiNardo, Tapan M. Kadia, Ayalew Tefferi

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: